Kanji Nakatsu, Professor Emeritus of Pharmacology at Queen’s University, discusses the potential importance of stress proteins in COVID-19 and how the enzyme Heme Oxygenase could be exploited for treatment.
“I wrote this essay because I thought it might facilitate organizing our thoughts of pharmacological/nutraceutical treatment of C19. A role for HO and CO in C19 is far from proven; please feel free to criticize these ideas. When I received my PhD from UBC in 1971, I didn’t think that I would be writing about CO in C19 half a century later.”
